annual retained earnings:
-$1.22B-$318.76M(-35.32%)Summary
- As of today (September 16, 2025), SNDX annual retained earnings is -$1.22 billion, with the most recent change of -$318.76 million (-35.32%) on December 31, 2024.
- During the last 3 years, SNDX annual retained earnings has fallen by -$677.46 million (-124.60%).
- SNDX annual retained earnings is now -1672.36% below its all-time high of -$68.90 million, reached on December 1, 2011.
Performance
SNDX Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$1.38B-$71.85M(-5.50%)Summary
- As of today (September 16, 2025), SNDX quarterly retained earnings is -$1.38 billion, with the most recent change of -$71.85 million (-5.50%) on June 30, 2025.
- Over the past year, SNDX quarterly retained earnings has dropped by -$334.99 million (-32.12%).
- SNDX quarterly retained earnings is now -1006.92% below its all-time high of -$124.48 million, reached on September 30, 2013.
Performance
SNDX quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SNDX Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.3% | -32.1% |
| 3 y3 years | -124.6% | -122.8% |
| 5 y5 years | -146.5% | -161.1% |
SNDX Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -124.6% | at low | -122.8% | at low |
| 5 y | 5-year | -146.5% | at low | -161.1% | at low |
| alltime | all time | -1672.4% | at low | -1006.9% | at low |
SNDX Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$1.38B(+5.5%) |
| Mar 2025 | - | -$1.31B(+6.9%) |
| Dec 2024 | -$1.22B(+35.3%) | -$1.22B(+8.4%) |
| Sep 2024 | - | -$1.13B(+8.1%) |
| Jun 2024 | - | -$1.04B(+7.0%) |
| Mar 2024 | - | -$974.80M(+8.0%) |
| Dec 2023 | -$902.40M(+30.2%) | -$902.40M(+8.7%) |
| Sep 2023 | - | -$829.93M(+6.6%) |
| Jun 2023 | - | -$778.78M(+6.1%) |
| Mar 2023 | - | -$734.17M(+5.9%) |
| Dec 2022 | -$693.04M(+27.5%) | -$693.04M(+6.0%) |
| Sep 2022 | - | -$653.85M(+5.7%) |
| Jun 2022 | - | -$618.44M(+6.5%) |
| Mar 2022 | - | -$580.87M(+6.8%) |
| Dec 2021 | -$543.70M(-4.4%) | -$543.70M(-15.0%) |
| Sep 2021 | - | -$639.90M(+3.3%) |
| Jun 2021 | - | -$619.26M(+3.8%) |
| Mar 2021 | - | -$596.35M(+4.9%) |
| Dec 2020 | -$568.63M(+14.8%) | -$568.63M(+3.7%) |
| Sep 2020 | - | -$548.21M(+3.9%) |
| Jun 2020 | - | -$527.77M(+3.3%) |
| Mar 2020 | - | -$510.71M(+3.1%) |
| Dec 2019 | -$495.47M | -$495.47M(+2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -$481.47M(+2.7%) |
| Jun 2019 | - | -$468.64M(+3.3%) |
| Mar 2019 | - | -$453.73M(+3.3%) |
| Dec 2018 | -$439.42M(+20.0%) | -$439.42M(+4.5%) |
| Sep 2018 | - | -$420.59M(+4.3%) |
| Jun 2018 | - | -$403.25M(+4.8%) |
| Mar 2018 | - | -$384.86M(+5.1%) |
| Dec 2017 | -$366.11M(+19.9%) | -$366.11M(+5.5%) |
| Sep 2017 | - | -$347.01M(+4.5%) |
| Jun 2017 | - | -$331.92M(+4.3%) |
| Mar 2017 | - | -$318.28M(+4.3%) |
| Dec 2016 | -$305.29M(+17.6%) | -$305.29M(+3.7%) |
| Sep 2016 | - | -$294.48M(+5.4%) |
| Jun 2016 | - | -$279.51M(+3.1%) |
| Mar 2016 | - | -$271.15M(+74.9%) |
| Dec 2015 | -$259.68M(+62.5%) | - |
| Dec 2014 | -$159.80M(+17.8%) | - |
| Sep 2014 | - | -$155.02M(+5.8%) |
| Jun 2014 | - | -$146.48M(+4.1%) |
| Mar 2014 | - | -$140.73M(+3.7%) |
| Dec 2013 | -$135.71M(+71.7%) | -$135.71M(+9.0%) |
| Sep 2013 | - | -$124.48M |
| Dec 2012 | -$79.05M(+14.7%) | - |
| Dec 2011 | -$68.90M | - |
FAQ
- What is Syndax Pharmaceuticals, Inc. annual retained earnings?
- What is the all time high annual retained earnings for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. annual retained earnings year-on-year change?
- What is Syndax Pharmaceuticals, Inc. quarterly retained earnings?
- What is the all time high quarterly retained earnings for Syndax Pharmaceuticals, Inc.?
- What is Syndax Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
What is Syndax Pharmaceuticals, Inc. annual retained earnings?
The current annual retained earnings of SNDX is -$1.22B
What is the all time high annual retained earnings for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high annual retained earnings is -$68.90M
What is Syndax Pharmaceuticals, Inc. annual retained earnings year-on-year change?
Over the past year, SNDX annual retained earnings has changed by -$318.76M (-35.32%)
What is Syndax Pharmaceuticals, Inc. quarterly retained earnings?
The current quarterly retained earnings of SNDX is -$1.38B
What is the all time high quarterly retained earnings for Syndax Pharmaceuticals, Inc.?
Syndax Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$124.48M
What is Syndax Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?
Over the past year, SNDX quarterly retained earnings has changed by -$334.99M (-32.12%)